- Report
- June 2020
- 183 Pages
Spain
From €5760EUR$5,995USD£4,945GBP
- Report
- June 2020
- 181 Pages
Russia
From €5760EUR$5,995USD£4,945GBP
- Report
- June 2020
- 260 Pages
France
From €5760EUR$5,995USD£4,945GBP
- Report
- June 2020
- 305 Pages
United Kingdom
From €5760EUR$5,995USD£4,945GBP
- Report
- June 2020
- 224 Pages
Japan
From €5760EUR$5,995USD£4,945GBP
- Report
- February 2019
- 68 Pages
Global
From €4564EUR$4,750USD£3,918GBP
- Report
- February 2022
- 186 Pages
Global
From €5926EUR$6,168USD£5,088GBP
- Book
- November 2019
- 176 Pages
Bone Densitometry is a type of radiography used to measure bone mineral density (BMD). It is used to diagnose and monitor osteoporosis, a condition in which bones become weak and brittle due to a decrease in BMD. Bone densitometry is also used to assess fracture risk and to monitor the effectiveness of treatments for osteoporosis.
Bone densitometry is typically performed using dual-energy X-ray absorptiometry (DXA) or quantitative computed tomography (QCT). DXA is the most commonly used method and is used to measure BMD in the spine, hip, and forearm. QCT is used to measure BMD in the spine and hip.
Bone densitometry is a growing market, with an increasing number of healthcare providers offering the service. The market is driven by the increasing prevalence of osteoporosis, the development of new technologies, and the increasing demand for early diagnosis and treatment of the condition.
Some companies in the Bone Densitometry market include Hologic, GE Healthcare, Siemens Healthineers, Canon Medical Systems, and Shimadzu Corporation. Show Less Read more